nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Brompheniramine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Brompheniramine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Brompheniramine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Brompheniramine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Brompheniramine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Brompheniramine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Brompheniramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Brompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Brompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Brompheniramine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.001	0.001	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.001	0.001	CbGpPWpGaD
Brompheniramine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.001	0.001	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.001	0.001	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.001	0.001	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000998	0.000998	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.000995	0.000995	CbGpPWpGaD
Brompheniramine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000993	0.000993	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CHKB—narcolepsy	0.000991	0.000991	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.000985	0.000985	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000983	0.000983	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.000974	0.000974	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00096	0.00096	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.000932	0.000932	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.000915	0.000915	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.000915	0.000915	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.000909	0.000909	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.000906	0.000906	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.000904	0.000904	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000896	0.000896	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.000895	0.000895	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.000891	0.000891	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.000876	0.000876	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.000876	0.000876	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000865	0.000865	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000862	0.000862	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000859	0.000859	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.000853	0.000853	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CHKB—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.000849	0.000849	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.000846	0.000846	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.000838	0.000838	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CHKB—narcolepsy	0.000835	0.000835	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.000831	0.000831	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.000831	0.000831	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PENK—narcolepsy	0.000794	0.000794	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.000773	0.000773	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000771	0.000771	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.000768	0.000768	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000761	0.000761	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PENK—narcolepsy	0.000761	0.000761	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.000747	0.000747	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000744	0.000744	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000742	0.000742	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000735	0.000735	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.000734	0.000734	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.000734	0.000734	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000732	0.000732	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000732	0.000732	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.000729	0.000729	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.000729	0.000729	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CHKB—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.000709	0.000709	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000707	0.000707	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000704	0.000704	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000697	0.000697	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.000678	0.000678	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000676	0.000676	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000675	0.000675	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000674	0.000674	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CPT1B—narcolepsy	0.000673	0.000673	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000667	0.000667	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.000659	0.000659	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000656	0.000656	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000654	0.000654	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000648	0.000648	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000647	0.000647	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CHKB—narcolepsy	0.000644	0.000644	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000639	0.000639	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.000619	0.000619	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.000619	0.000619	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000617	0.000617	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000617	0.000617	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000615	0.000615	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000615	0.000615	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000609	0.000609	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000609	0.000609	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.000603	0.000603	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000601	0.000601	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000599	0.000599	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000593	0.000593	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000592	0.000592	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000592	0.000592	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CHKB—narcolepsy	0.000587	0.000587	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000567	0.000567	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000567	0.000567	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.000562	0.000562	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.000562	0.000562	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.00056	0.00056	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.00056	0.00056	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000558	0.000558	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000558	0.000558	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000553	0.000553	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000553	0.000553	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.00055	0.00055	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PENK—narcolepsy	0.000537	0.000537	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000535	0.000535	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000534	0.000534	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000529	0.000529	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000527	0.000527	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.0005	0.0005	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000491	0.000491	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000491	0.000491	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CPT1B—narcolepsy	0.00049	0.00049	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000478	0.000478	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NPS—narcolepsy	0.00047	0.00047	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.00047	0.00047	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TRH—narcolepsy	0.000457	0.000457	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000455	0.000455	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000454	0.000454	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000449	0.000449	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000438	0.000438	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000403	0.000403	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.000401	0.000401	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000399	0.000399	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000399	0.000399	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000398	0.000398	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000394	0.000394	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000387	0.000387	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.000372	0.000372	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000371	0.000371	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.00037	0.00037	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000366	0.000366	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.000338	0.000338	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000337	0.000337	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000336	0.000336	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000333	0.000333	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.000332	0.000332	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NPS—narcolepsy	0.000332	0.000332	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000331	0.000331	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000331	0.000331	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.00033	0.00033	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.00033	0.00033	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000327	0.000327	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000327	0.000327	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000295	0.000295	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000283	0.000283	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000263	0.000263	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.0002	0.0002	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000199	0.000199	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000198	0.000198	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000196	0.000196	CbGpPWpGaD
